Document Detail


Innate immune activation by the viral PAMP poly I:C potentiates pulmonary graft-versus-host disease after allogeneic hematopoietic cell transplant.
MedLine Citation:
PMID:  21070856     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Respiratory viral infections cause significant morbidity and increase the risk for chronic pulmonary graft-versus-host disease (GVHD) after hematopoietic cell transplantation (HCT). Our overall hypothesis is that local innate immune activation potentiates adaptive alloimmunity. In this study, we hypothesized that a viral pathogen-associated molecular pattern (PAMP) alone can potentiate pulmonary GVHD after allogeneic HCT. We, therefore, examined the effect of pulmonary exposure to polyinosinic:polycytidylic acid (poly I:C), a viral mimetic that activates innate immunity, in an established murine HCT model. Poly I:C-induced a marked pulmonary T cell response in allogeneic HCT mice as compared to syngeneic HCT, with increased CD4+ cells in the lung fluid and tissue. This lymphocytic inflammation persisted at 2 weeks post poly I:C exposure in allogeneic mice and was associated with CD3+ cell infiltration into the bronchiolar epithelium and features of epithelial injury. In vitro, poly I:C enhanced allospecific proliferation in a mixed lymphocyte reaction. In vivo, poly I:C exposure was associated with an early increase in pulmonary monocyte recruitment and activation as well as a decrease in CD4+FOXP3+ regulatory T cells in allogeneic mice as compared to syngeneic. In contrast, intrapulmonary poly I:C did not alter the extent of systemic GVHD in either syngeneic or allogeneic mice. Collectively, our results suggest that local activation of pulmonary innate immunity by a viral molecular pattern represents a novel pathway that contributes to pulmonary GVHD after allogeneic HCT, through a mechanism that includes increased recruitment and maturation of intrapulmonary monocytes.
Authors:
Christine V Kinnier; Tereza Martinu; Kymberly M Gowdy; Julia L Nugent; Francine L Kelly; Scott M Palmer
Related Documents :
14555846 - Human herpesvirus-6: a short review of its biological behavior.
11082776 - The common cold.
19649986 - Systemic delivery of therapeutic viruses.
18261236 - Apoptosis resistance in hiv-1 persistently-infected cells is independent of active vira...
14685686 - The art of war: innate and adaptive immune responses.
20719936 - Pregnane x receptor is sumoylated to repress the inflammatory response.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't     Date:  2010-11-09
Journal Detail:
Title:  Transplant immunology     Volume:  24     ISSN:  1878-5492     ISO Abbreviation:  Transpl. Immunol.     Publication Date:  2011 Jan 
Date Detail:
Created Date:  2010-12-27     Completed Date:  2011-07-07     Revised Date:  2012-05-10    
Medline Journal Info:
Nlm Unique ID:  9309923     Medline TA:  Transpl Immunol     Country:  England    
Other Details:
Languages:  eng     Pagination:  83-93     Citation Subset:  IM    
Copyright Information:
Copyright © 2010 Elsevier B.V. All rights reserved.
Affiliation:
Department of Medicine, Duke University Medical Center, 106 Research Drive, Building MSRB2 Room 2100B, Durham, NC 27710, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adaptive Immunity
Animals
Antigens, CD3
CD4-Positive T-Lymphocytes / immunology
Flow Cytometry
Graft vs Host Disease / immunology*
Hematopoietic Stem Cell Transplantation*
Immunity, Innate*
Lung / immunology*
Lung Diseases / immunology*
Mice
Mice, Inbred C57BL
Monocytes / immunology*
Monocytes, Activated Killer / immunology
Poly I-C / immunology*
Respiratory Mucosa / immunology
Respiratory Tract Infections / virology
T-Lymphocytes, Regulatory / immunology
Transplantation, Homologous
Grant Support
ID/Acronym/Agency:
1 K24 HL091140/HL/NHLBI NIH HHS; 1P50-HL084917-011/HL/NHLBI NIH HHS; K24 HL091140/HL/NHLBI NIH HHS; K24 HL091140-01A1/HL/NHLBI NIH HHS; K24 HL091140-02/HL/NHLBI NIH HHS; K24 HL091140-04/HL/NHLBI NIH HHS; KL2 RR024127-03/RR/NCRR NIH HHS; P50 HL084917-01/HL/NHLBI NIH HHS; P50 HL084917-02/HL/NHLBI NIH HHS; P50 HL084917-03/HL/NHLBI NIH HHS; P50 HL084917-04/HL/NHLBI NIH HHS; RR024 127-03/RR/NCRR NIH HHS
Chemical
Reg. No./Substance:
0/Antigens, CD3; 24939-03-5/Poly I-C

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Mutation of a novel virulence-related gene mltD in Vibrio anguillarum enhances lethality in zebra fi...
Next Document:  Activation and localization of protein kinase C in Neurospora crassa.